Based on observations of the immunosuppressive microenvironment of advanced thyroid tumors and prior studies of the possible immune-potentiating effects of BRAF inhibitors, several studies have evaluated the efficacy of combined BRAF blockade with immunotherapy. The gene discussed is BRAF; the disease is thyroid tumor.